These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 18384283)
41. Gene doping detection: evaluation of approach for direct detection of gene transfer using erythropoietin as a model system. Baoutina A; Coldham T; Bains GS; Emslie KR Gene Ther; 2010 Aug; 17(8):1022-32. PubMed ID: 20463760 [TBL] [Abstract][Full Text] [Related]
42. The physiology of growth hormone and sport. Widdowson WM; Healy ML; Sönksen PH; Gibney J Growth Horm IGF Res; 2009 Aug; 19(4):308-19. PubMed ID: 19505835 [TBL] [Abstract][Full Text] [Related]
44. Gene doping: an overview and current implications for athletes. van der Gronde T; de Hon O; Haisma HJ; Pieters T Br J Sports Med; 2013 Jul; 47(11):670-8. PubMed ID: 23322893 [TBL] [Abstract][Full Text] [Related]
45. The human genome and sport, including epigenetics, gene doping, and athleticogenomics. Sharp NC Endocrinol Metab Clin North Am; 2010 Mar; 39(1):201-15, xi. PubMed ID: 20122459 [TBL] [Abstract][Full Text] [Related]
46. [Erythropoietin: indications and measurement]. Klein E; Georges A; Brossaud J; Bosredon Kd; Bordenave L; Corcuff JB Ann Biol Clin (Paris); 2009; 67(5):505-15. PubMed ID: 19789122 [TBL] [Abstract][Full Text] [Related]
48. Human genetic variation: new challenges and opportunities for doping control. Schneider AJ; Fedoruk MN; Rupert JL J Sports Sci; 2012; 30(11):1117-29. PubMed ID: 22681541 [TBL] [Abstract][Full Text] [Related]
49. Blood transfusions in athletes. Old dogmas, new tricks. Lippi G; Banfi G Clin Chem Lab Med; 2006; 44(12):1395-402. PubMed ID: 17163813 [TBL] [Abstract][Full Text] [Related]
50. Monitoring recombinant human erythropoietin abuse among athletes. Citartan M; Gopinath SCB; Chen Y; Lakshmipriya T; Tang TH Biosens Bioelectron; 2015 Jan; 63():86-98. PubMed ID: 25058943 [TBL] [Abstract][Full Text] [Related]
51. A fast screening method for the detection of the abuse of hemoglobin-based oxygen carriers (HBOCs) in doping control. Donati F; Botrè F Talanta; 2010 Apr; 81(1-2):252-4. PubMed ID: 20188917 [TBL] [Abstract][Full Text] [Related]
52. American College of Sports Medicine position stand on blood doping as an ergogenic aid. Med Sci Sports Exerc; 1987 Oct; 19(5):540-3. PubMed ID: 3316908 [TBL] [Abstract][Full Text] [Related]
53. Altitude Training and Recombinant Human Erythropoietin: Considerations for Doping Detection. Sutehall S; Muniz-Pardos B; Lima G; Wang G; Malinsky FR; Bosch A; Zelenkova I; Tanisawa K; Pigozzi F; Borrione P; Pitsiladis Y Curr Sports Med Rep; 2019 Apr; 18(4):97-104. PubMed ID: 30969231 [TBL] [Abstract][Full Text] [Related]
54. Biochemistry, physiology, and complications of blood doping: facts and speculation. Lippi G; Franchini M; Salvagno GL; Guidi GC Crit Rev Clin Lab Sci; 2006; 43(4):349-91. PubMed ID: 16769597 [TBL] [Abstract][Full Text] [Related]
55. Supplements and sports. Jenkinson DM; Harbert AJ Am Fam Physician; 2008 Nov; 78(9):1039-46. PubMed ID: 19007050 [TBL] [Abstract][Full Text] [Related]
56. Current strategic approaches for the detection of blood doping practices. Segura J; Ventura R; Pascual JA Forensic Sci Int; 2011 Dec; 213(1-3):42-8. PubMed ID: 21889274 [TBL] [Abstract][Full Text] [Related]